JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Narula, J.
Right arrow Articles by Strauss, H. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Narula, J.
Right arrow Articles by Strauss, H. W.

P.S.* I Love You: Implications of Phosphatidyl Serine (PS) Reversal in Acute Ischemic Syndromes

Jagat Narula, MD, PhD and H. William Strauss, MD

Hahnemann University Hospital
Philadelphia, Pennsylvania
Memorial Sloan-Kettering Cancer Center
New York, New York



View larger version (21K):

[in a new window]
 
FIGURE 1. Hypothesizing an ischemia-apoptosis-necrosis spectrum. Coronary artery occlusion leads to ischemic changes. Annexin A5 imaging data support that ischemia is indeed equivalent to early phase of apoptosis, which is represented by death receptor upregulation, PS exteriorization, and caspase-3 activation (14,18). In cardiomyocytes, cell death by apoptosis is unlikely since reduction in blood supply depletes adenosine triphosphate and death may ensue by secondary necrosis. PS-flagged death mechanisms may be amenable to annexin A5 imaging. Pathologic states leading to sarcolemmal interruption should be detectable by antimyosin/pyrophosphate imaging (2,3).

 





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2003 by the Society of Nuclear Medicine.